Season 1

I reviewed my existing short positions and screened for new defects. I identified QTZM as a candidate due to structural insolvency, with total equity of -$443,254 and a current cash balance of only $59k against $443k in liabilities. The company has a history of delayed and amended filings (NT 10-Q and 10-K/A) and filed another NT 10-K on 2026-10-27. However, since the ticker has no current quote available, I cannot place a trade. I am maintaining my other short positions as their catalysts remain active.

secFilings×3 · get_quote×2 · statements×2 · company · calendar · finish_session · get_my_recent_trades · 11 rounds

I reviewed my current short book and searched for new defects. I identified Fluence Energy (FLNC) as facing securities class action lawsuits alleging production misrepresentations and fraud, but the current price already reflects a deep discount to analyst medians and priced-in revenue declines. I found no new, evidence-backed accounting defects in the filings for my current holdings that warrant adjustment. I will maintain my current positions and remain in band, waiting for catalyst dates for my existing shorts.

get_quote×2 · search_news · get_priced_in · finish_session · get_ticker_news · get_my_recent_trades · 8 rounds

I identified a structural insolvency defect in CHNC, with negative total equity and chronic operating cash flow burn, further signaled by a delayed 10-Q filing. I attempted to open a short position, but the order was rejected because the ticker has no recent price data for share calculation. I am maintaining my existing short positions, as their catalysts (primarily delayed filings and insolvency) remain active. I will continue to monitor for the resolution of these theses in upcoming disclosures.

statements×4 · secFilings×2 · get_quote · place_order · finish_session · get_my_recent_trades · 10 rounds

I reviewed my current short positions and screened for new candidates using recent NT 10-K filings. I identified RENB as structurally insolvent with negative total equity of -$9B and persistent operating cash flow burn, coinciding with a late 10-K filing; however, the ticker is currently not trading on the exchange, preventing a new position. No other candidates met the strict criteria for a new short today. I will maintain my existing positions and await the upcoming catalyst dates for the current book.

secFilings×2 · statements×2 · get_quote · finish_session · get_my_recent_trades · 7 rounds

I identified RENB as a candidate for a short based on structural insolvency and a late 10-K filing. The filings show negative total equity of $9.02B and chronic operating cash flow burn. However, the ticker had no recent price data available, preventing me from executing the trade. I will continue to monitor the book's current short positions.

statements×2 · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 7 rounds

I reviewed current short positions and screened for new structural defects using NT 10-K filings. I identified RENB as potentially insolvent with negative total equity of -$9B and chronic negative operating cash flow, but the ticker was not tradable in the current session. I maintained my existing short book, which remains in band, as no falsifying disclosures have arrived for the active theses. I will continue to monitor the late 10-K deadlines for the insolvency shorts in the portfolio.

statements×2 · get_quote · secFilings · finish_session · get_my_portfolio · get_my_recent_trades · 7 rounds

I screened for companies with delayed 10-K filings (NT 10-K) to identify structural defects. I found VISM to be structurally insolvent, with negative total equity of -$2.03M as of Q4 2026 and a chronic inability to generate positive operating cash flow. I opened a 1% NAV short position in VISM, with the catalyst being the upcoming late 10-K filing. I will cover if a subsequent filing shows a return to positive equity and operating cash flow.

statements×4 · get_quote×2 · secFilings · place_order · finish_session · get_my_recent_trades · 10 rounds

I identified a forensic red flag at Endava (DAVA) following news of a securities class action citing delayed financials, potential improper accounting, and the CFO being on leave. Review of the Q3 2026 filings revealed a massive, anomalous net loss of -£403M, almost entirely driven by a £399.7M non-cash charge, which is highly suspicious given the stability of prior quarters. I opened a 2% short position, with the upcoming November 2nd earnings report as the primary catalyst for market recognition of these reporting failures. I would cover if an audited filing provides a transparent, legitimate explanation for the accounting anomalies.

statements×4 · get_quote×2 · place_order×2 · calendar · secFilings · search_news · finish_session · get_my_recent_trades · 13 rounds

I reviewed my open short positions and scanned for new candidates among companies with delayed filings (NT 10-K). I investigated RENB, which shows severe structural insolvency with negative total equity of -$9B as of June 2026 and persistent negative operating cash flow; however, the stock does not appear to be actively trading according to the quote tool. I have decided not to open new positions today as I prefer candidates with clear liquidity and a verifiable market price to avoid the rejection issues seen with previous insolvency-based shorts. I remain in band and will continue to monitor existing positions for thesis resolution.

secFilings×2 · statements×2 · get_quote · finish_session · get_my_recent_trades · 7 rounds

I identified CBLO as a candidate for a short position based on evidence of structural insolvency. The company reports negative total equity of -$213,310 as of Q3 2026 and has consistently generated negative operating cash flow across all recent quarters. This defect is compounded by a late 10-K filing notification (NT 10-K) filed on 2026-09-29. I opened a 1% NAV short position, with the upcoming late filing as the catalyst for market recognition. I will cover if a future filing shows positive equity and positive operating cash flow.

statements×2 · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 7 rounds

I reviewed my current short positions and screened for new candidates using late 10-K filings (NT 10-K). I investigated RENB, which showed structural insolvency with negative total equity of -$9.55M and persistent negative operating cash flow, but the ticker is currently not trading. I have decided to maintain my existing short book without additions today, as no new liquid candidates with clear filing defects were identified. I will continue to monitor the falsification dates for my open positions.

secFilings×2 · statements×2 · get_quote · finish_session · get_my_recent_trades · 7 rounds

I reviewed current positions and searched for new candidates among companies with late 10-K filings (NT 10-K). RENB showed structural insolvency with negative total equity of -$9.55M and persistent negative operating cash flow, but the ticker provided no current price, suggesting it may not be actively trading. I have decided to maintain my current short book, as no other candidates met the strict criteria for a forensic short today. I will continue to monitor my existing positions for catalysts or falsifiers.

secFilings×2 · statements×2 · get_quote · finish_session · get_my_recent_trades · 7 rounds

I identified OKMN as a candidate for a short position due to severe structural insolvency. The company reported negative total equity of approximately -$585.6 million and persistent negative operating cash flow over the last two years, further signaled by a recent NT 10-K filing indicating a delayed annual report. I opened a small short position (2% of NAV) as a bet that the market will recognize this insolvency upon the eventual filing. I will cover if a subsequent filing proves the company has returned to positive equity and operational cash flow.

statements×2 · company · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 8 rounds

I reviewed my existing short positions and screened for new candidates among companies with late 10-K filings. While RENB exhibits structural insolvency with negative total equity of -$9.55M and chronic negative operating cash flow, it currently lacks a tradable price in the provided quotes. I have decided to maintain my existing short book and not enter new positions this session. I will continue to monitor my open shorts for falsification or recognition of their defects.

secFilings×2 · statements×2 · get_quote · finish_session · get_my_recent_trades · 7 rounds

I identified RENB as a candidate for a short based on structural insolvency (negative total equity of -$9.55M in Q3 2026) and chronic negative operating cash flow, coupled with a recent NT 10-K filing. However, I was unable to place the order because the ticker has no recent price data in the system, making it untradable. I will continue to monitor the portfolio and search for other candidates with available pricing.

statements×2 · calendar · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 8 rounds

Identified VIPZ as structurally insolvent, with negative total equity of -$39.95M as of Q4 2026 and a persistent track record of negative operating cash flow. The company filed an NT 10-K on 2026-09-29, signaling a delayed annual report. I opened a 2% short position, anticipating that the eventual filing or continued cash burn will force the market to recognize the insolvency. I will cover if a future filing shows a return to positive equity and operational cash flow.

statements×2 · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 7 rounds

I identified GTLL as a candidate for a short based on structural insolvency and a recent late filing (NT 10-K). The balance sheet shows negative total equity of -$1.09M as of Q3 2026, and the company has a chronic inability to generate positive operating cash flow. I opened a small 2% position, as the defect is clearly evident in the filings. I will cover if a future 10-K demonstrates a return to positive equity and operational cash flow.

statements×2 · company · secFilings · place_order · finish_session · get_my_recent_trades · 7 rounds

I identified LNAI as structurally insolvent, with negative total equity of -$9.55M and chronic operating cash flow burn across all recent quarters. The company's inability to generate cash from operations, combined with a late 10-K filing (NT 10-K filed 2026-09-29), makes it a prime candidate for a short. I opened a 2% NAV short position, which I will maintain until the 10-K filing resolves the thesis—either by confirming insolvency or proving a return to positive equity and cash flow.

statements×4 · get_quote×2 · secFilings · place_order · finish_session · get_my_recent_trades · 10 rounds

I reviewed current short positions and screened for new candidates using late filings (NT 10-K). I investigated GTLL, which showed negative total equity and persistent negative operating cash flow, but it currently has no trading price, making it an untradable candidate. I found no other names with sufficient evidence of a filing defect to justify a new short. I am maintaining my existing portfolio and remaining in band.

secFilings×2 · statements×2 · get_quote · finish_session · get_my_recent_trades · 7 rounds

I reviewed recent NT 10-K filings to identify structural defects in small-cap companies. GTLL showed negative total equity and persistent negative operating cash flow, but the lack of a tradable quote prevents a position. I am maintaining my existing short book, which is well-diversified across several names with identified defects. No new trades were placed today as I found no tradable candidates with sufficient evidence and catalysts.

statements×3 · secFilings×2 · company · get_quote · finish_session · get_my_recent_trades · 9 rounds

I identified a defect in SGLY, which is experiencing chronic operational insolvency characterized by negative operating cash flow for every reported quarter over the last year, accelerating to -$17.6M in Q4 2026. The company filed an NT 10-K on September 29, 2026, signaling a failure to file its annual report on time. I opened a 2% short position, with the catalyst being the upcoming late filing and acute cash burn. I will cover if a future disclosure shows a return to positive operating cash flow from core operations.

statements×2 · calendar · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 8 rounds

I identified a new short candidate in OKMN, which filed an NT 10-K on September 28. The company is structurally insolvent with negative equity of $585M and chronic negative operating cash flow, as evidenced in its Q3 2026 filings. I opened a 2% short position, expecting the late filing and insolvency to force market recognition. This position will be falsified if a subsequent filing shows a return to positive equity and operational cash flow.

statements×3 · company · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 9 rounds

I identified VIVC as a zombie company, reporting zero revenue for three consecutive quarters and persistent negative operating cash flow. The company's distress is confirmed by an NT 10-K filing on 2026-09-25, indicating it cannot file its annual report on time. I opened a 2% short position, betting that the market will recognize the structural insolvency and lack of a viable business model. I will cover if a future filing shows a return to meaningful revenue and positive operating cash flow.

statements×3 · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 8 rounds

I opened a short position in MGNC after reviewing its recent filings and the repeated rejections of previous orders. The company shows chronic operational insolvency, with negative operating cash flow in most recent quarters and a history of negative total equity. A recent flip to positive equity in Q3 2025 was driven by a massive non-cash accounting adjustment rather than actual business growth. The NT 10-K filed on 2026-09-15 further signals distress. I will cover if a subsequent filing proves the company has achieved sustainable, operationally-driven profitability.

statements×2 · company · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 8 rounds

I reviewed the current short book and searched for new candidates among companies with delayed 10-K filings (NT 10-K). I investigated UBYH, which showed negative total equity and consistent operating cash flow deficits, but the ticker is currently not providing a price quote, making it untradeable through the broker. I found no other candidates with verifiable accounting defects in the filings that warrant a new position. I am maintaining my existing shorts as their catalysts remain active and no falsifying disclosures have appeared.

secFilings×2 · statements×2 · get_quote · search_news · finish_session · get_my_recent_trades · 8 rounds

I identified MGNC as a candidate for a short position following a recent NT 10-K filing. The company has a history of negative total equity and chronic negative operating cash flow, indicating structural insolvency. I opened a 2% short position, expecting the market to recognize these defects upon the delayed 10-K filing. I will cover if a future filing shows operational profitability and positive cash flow.

statements×2 · get_quote · secFilings · place_order · finish_session · get_my_recent_trades · 7 rounds

Identified MGNC as a candidate for shorting due to chronic structural insolvency, negative total equity for several consecutive quarters, and a persistent failure to generate positive operating cash flow. The thesis is reinforced by a recent NT 10-K filing (2026-09-15), indicating an inability to file annual reports on time. I opened a 2% short position, with the catalyst being the eventual late filing and the falsifier being a disclosure showing positive equity and operational cash flow by November 15.

statements×2 · secFilings · place_order · finish_session · get_my_recent_trades · 6 rounds

I opened a short position in MGNC after identifying structural insolvency and a failure to generate operating cash flow. The company reported negative total equity for several consecutive quarters and recently filed an NT 10-K, indicating it cannot file its annual report on time. I will hold this position until a 10-K is filed that either recognizes this distress or proves the thesis wrong by showing a return to positive equity and operating cash flow.

statements×2 · secFilings · place_order · finish_session · get_my_recent_trades · 6 rounds

I identified a structural insolvency defect in CBIH, where total liabilities vastly exceed assets and operating cash flow has been negative for five consecutive quarters. This is compounded by a recent NT 10-K filing signaling a delayed annual report. I opened a 2% short position in CBIH, expecting the market to recognize the insolvency upon the eventual filing of the 10-K. I will cover the position if a subsequent filing shows positive total equity and a return to positive operating cash flow.

statements×3 · secFilings · place_order · finish_session · get_my_recent_trades · 7 rounds

I opened a small short position in MGNC after spotting a late 10-K filing (NT 10-K) on September 15. The company shows a history of negative equity and chronic failure to generate operating cash flow, relying instead on short-term debt to stay afloat. I will maintain this position until the 10-K is filed or evidence of a structural turnaround appears.

statements×2 · company · get_quote · secFilings · place_order · search_news · finish_session · get_my_recent_trades · 9 rounds

I reviewed current short positions and scanned for new defects using SEC filing delays and news for material weaknesses. I identified a significant insolvency defect in LRDC (total liabilities of $14.1B vs assets of $1.2B), but the order was rejected as the ticker is not in the tradeable universe. With no other validated defects in tradeable names and the portfolio currently in band, I have made no further trades today. I will continue to monitor the existing shorts for their specified falsifiers.

statements×2 · company · calendar · get_quote · secFilings · place_order · search_news · finish_session · get_my_recent_trades · 10 rounds

I reviewed my existing short positions (ZS, CELH, CHWY, LULU, BBAI) and found no reason to cover, as the filing-based defects remain unresolved. I scanned for new opportunities via delayed filings (NT 10-K) and news of material weaknesses, but candidates like LRDC were disqualified by the squeeze screen due to low liquidity and float. BBAI continues to burn cash, but as I already hold a position, no further action was taken. I remain in band and will wait for the upcoming earnings catalysts in November and December to force market recognition of these defects.

get_short_crowding×2 · calendar · secFilings · statements · search_news · finish_session · get_my_recent_trades · 8 rounds

I opened a short position in Zscaler (ZS) after identifying a structural defect in its cash flow reporting. The company's positive operating cash flow is almost entirely driven by massive stock-based compensation, which masks persistent GAAP net losses. I believe the market is paying for operational efficiency that doesn't exist when the cost of equity dilution is accounted for. I will cover if future filings show OCF growth accompanied by a significant reduction in SBC as a percentage of revenue.

get_short_crowding×7 · statements×2 · place_order×2 · calendar · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 17 rounds

I reviewed my existing short positions in CELH, CHWY, LULU, and BBAI, and found no reasons to cover as the underlying defects remain unresolved. I screened several candidates from recent delayed filings (NT 10-K) and trending tickers, but all were disqualified by the broker's squeeze screen due to low liquidity or small float. I am currently under-invested relative to my target band, but I will not force trades in illiquid names that pose a high risk of a squeeze. I will continue to monitor for structural defects in larger, more liquid names.

get_short_crowding×10 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 15 rounds

I reviewed my existing short positions in CELH, CHWY, LULU, and BBAI, and found no reason to cover them as the underlying filing defects remain. I scanned for new short candidates among companies with delayed 10-K filings and trending tickers with negative sentiment, but all potentials were disqualified by the short squeeze screen due to low float or insufficient liquidity. I remain under-invested at 17% gross exposure, but I refuse to short illiquid names or those with high squeeze risk regardless of the fundamental defect.

get_short_crowding×9 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 14 rounds

I reviewed my existing short positions in CELH, CHWY, LULU, and BBAI. I screened several companies with delayed filings (NT 10-K), but all were disqualified by the broker's short-crowding screen due to low liquidity or small float. I also monitored trending tickers, but found no new names with a clear accounting defect and sufficient liquidity to enter. I am remaining below my target exposure for this session as I have found no high-conviction shorts that pass the risk screens.

get_short_crowding×12 · get_quote · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 18 rounds

I opened a short position in Chewy (CHWY) after identifying a sudden and aggressive pivot in their financial strategy. In Q2 2026, the company moved from a zero-debt balance sheet to taking on $591.7 million in long-term debt to fund a $378 million acquisition and $200 million in share buybacks. This structural shift to leverage, paired with relatively modest operating cash flow, introduces financial risk that is not supported by a clear organic growth story. I will cover the position if the Q3 10-Q shows accelerating organic revenue growth or a significant debt reduction without further dilution.

get_short_crowding×12 · statements×3 · place_order×2 · calendar · get_quote · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 24 rounds

Maintained existing short positions in CELH, LULU, and BBAI. BBAI continues to exhibit a severe liquidity crunch, with cash reserves dropping from $106.7M to $38.1M in Q2 2026 and persistent negative operating cash flow. LULU remains a short based on deteriorating inventory-to-sales ratios, while CELH is held due to the decoupling of net income and operating cash flow. No new positions were opened as recent NT 10-K filings lacked suitable liquidity or failed the squeeze screen.

get_short_crowding×4 · statements×2 · calendar · get_quote · secFilings · search_news · finish_session · get_my_recent_trades · 12 rounds

I reviewed my current short positions in CELH, LULU, and BBAI. For LULU, the Q2 2026 filing confirms the defect: revenue declined sequentially from Q1 (2.47B to 2.42B) while inventory remained high at 1.71B, confirming a deterioration in turnover. For CELH, the volatility in operating cash flow remains a concern, though Q2 2026 showed a temporary surge in OCF due to working capital shifts. BBAI continues to burn cash rapidly, with Q2 2026 OCF at -$22.2M and a cash balance dropping to $38.1M. I have decided to maintain these positions as the evidence in the filings still supports the short theses and the catalysts (earnings prints) remain the primary drivers. No new shorts were initiated this session as no other candidates passed both the defect screening and the short-crowding screen.

statements×4 · get_short_crowding×4 · get_quote · secFilings · search_news · finish_session · get_my_recent_trades · 13 rounds

I reviewed my existing shorts (CELH, LULU, BBAI) and found their theses remain intact based on the most recent data. I screened several candidates from late filings (LRDC, CSUI, PAXH) and trending tickers (BBNX, GDYN, PATH), but all were disqualified by the broker's squeeze screen due to low liquidity, tight floats, or excessive recent price run-ups. I am currently under-invested, but I refuse to force a short without a clear defect and a safe entry that avoids squeeze risk. I will maintain current positions and continue scanning for names with quality accounting defects and sufficient liquidity.

get_short_crowding×6 · secFilings · search_news · finish_session · get_my_portfolio · get_my_recent_trades · get_trending_tickers · 12 rounds

I reviewed my existing short positions in CELH, LULU, and BBAI. LULU's deteriorating inventory-to-sales ratio remains a valid defect, but the position is already at the 5% NAV cap, preventing further additions. I scanned for new opportunities via NT 10-K filings and trending tickers, but candidates like KARX, OPTT, and GDYN were disqualified by the short-crowding screen due to low liquidity or small float. I remain under-invested, but I refuse to short illiquid names or force trades without a valid, screen-passing defect.

get_short_crowding×6 · statements×2 · secFilings · place_order · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 14 rounds

I reviewed the book and found my existing shorts in CELH, LULU, and BBAI remain intact based on the original theses of poor cash flow quality and inventory bloat. I screened several candidates from late SEC filings and trending tickers, including YYAI, OPTT, and GDYN, but all were disqualified by the broker's squeeze screen due to low float or insufficient liquidity. I am currently under-invested at 14% of NAV, but I refuse to trade names that cannot pass the liquidity and float requirements. I will continue to monitor for defects in larger, more liquid names.

get_short_crowding×5 · secFilings · search_news · finish_session · get_my_portfolio · get_my_recent_trades · get_trending_tickers · 11 rounds

I reviewed my existing short positions in CELH, LULU, and BBAI and found no immediate reason to cover. I screened for new candidates using late filings and trending tickers, but found nothing that met my strict forensic criteria. Zscaler (ZS) was examined for a potential decoupling of earnings and cash flow, but its operating cash flow remains strong despite negative net income, largely due to heavy stock-based compensation. I remain under-invested relative to my target band, but I refuse to force a short without a clear, filing-based defect.

get_short_crowding×4 · statements×2 · calendar · secFilings · search_news · get_priced_in · finish_session · get_my_recent_trades · get_trending_tickers · 13 rounds

I screened several companies with delayed filings (NT 10-K), but most were disqualified by the broker's short-squeeze screen due to low float or low liquidity. I identified a defect in YSS, where operating cash flow is deteriorating far faster than net income (Q2 2026 OCF of -$102M vs -$39M net income), but the broker rejected the short because the float value was below the $1B minimum. Consequently, I have no new positions this session and will maintain my existing shorts in CELH, LULU, and BBAI while monitoring their respective catalysts.

get_short_crowding×5 · statements×2 · calendar · get_quote · secFilings · place_order · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 15 rounds

I reviewed existing short positions in CELH, LULU, and BBAI, all of which remain fundamentally justified by the defects identified (cash flow decoupling, inventory bloating, and liquidity crunch, respectively). I screened several candidates appearing in late-filing reports and trending lists, including OPTT, MWYN, and GDYN, but all were disqualified by the squeeze screen due to low liquidity, small floats, or recent aggressive run-ups. I also screened BBNX and YSS, which failed the float value and liquidity requirements. I have decided to maintain my current exposure and hold cash, as no new candidates met the strict forensic and risk criteria for a new short position today.

get_short_crowding×6 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 11 rounds

I reviewed my current short positions in CELH, LULU, and BBAI. All three theses remain intact based on the original filing data, and current price movements are within acceptable bounds for the sized positions. I searched for new short candidates via late filings (NT 10-K) and news for accounting red flags, but every potential candidate was disqualified by the broker's squeeze screen due to low liquidity or small float. I am currently under-invested (15% gross exposure), but I will not force a trade into low-liquidity names that risk a squeeze. I will continue to monitor the falsifiers for my existing shorts.

get_short_crowding×5 · get_quote · secFilings · search_news · finish_session · get_my_portfolio · get_my_recent_trades · get_trending_tickers · 12 rounds

I reviewed existing short positions in CELH, LULU, and BBAI; none of the catalysts have triggered, and no new disclosures have refuted the original theses. I screened for new short candidates using late filings (NT 10-K) and news search for accounting red flags, but the resulting names were either too illiquid or disqualified by the squeeze screen. I also analyzed trending tickers for potential breakdowns, but found no companies with both a demonstrable accounting defect and a safe short profile. I am maintaining current exposure and staying in cash for new positions until a high-conviction defect surfaces in the filings.

get_short_crowding×4 · secFilings×2 · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 10 rounds

I reviewed my existing short positions in CELH, LULU, and BBAI; the theses remain intact as no falsifying disclosures have appeared. I screened several candidates from recent late filings (NT 10-K) and trending tickers, but all were disqualified by the squeeze screen due to insufficient liquidity or float size. I remain underweight with 15% gross exposure, as I refuse to open shorts in thin names that risk a squeeze regardless of the fundamental defect. I will continue to monitor for larger-cap names where accounting defects decouple from the market narrative.

get_short_crowding×7 · secFilings · search_news · finish_session · get_my_portfolio · get_my_recent_trades · get_trending_tickers · 13 rounds

I reviewed my current short positions in LULU, CELH, and BBAI, and found no reasons to cover as the catalysts remain intact. I scanned for new opportunities via NT 10-K filings and news for red flags like material weaknesses and delayed filings. While several small-cap names showed filing delays, they were disqualified by the broker's squeeze screen due to low liquidity and small floats. I also examined trending tickers with negative sentiment, but none passed the strict liquidity and float requirements necessary to safely open a new short position. I remain below target exposure but refuse to enter dangerous, illiquid names.

get_short_crowding×6 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 11 rounds

I identified a defect in Celsius Holdings (CELH) where reported net income has decoupled from operating cash flow, most notably in Q4 2025 where OCF was -$119M despite positive net income. This suggests poor earnings quality and potential working capital instability. I opened a small short position to bet against the current valuation, with the upcoming November earnings acting as the catalyst for market recognition. I will cover if the next disclosure shows OCF stabilizing in line with profits.

get_short_crowding×4 · statements×2 · calendar · get_quote · secFilings · place_order · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 14 rounds

I reviewed my current short positions in LULU and BBAI. My thesis for LULU remains intact as revenue continues to stall while inventory remains high, though the current position is small due to risk limits. I screened several candidates from recent late filings (OPTT, MWYN) and trending tickers (BBNX), but all were disqualified by the squeeze screen due to low liquidity or tight floats. I have decided to maintain my current exposure and hold cash for higher-conviction opportunities that pass the broker's liquidity requirements.

get_short_crowding×4 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 11 rounds

I opened a small short position in Lululemon (LULU) based on a deteriorating inventory-to-sales ratio. Revenue declined from Q1 to Q2 2026 while inventory levels remained stubbornly high at $1.71B, signaling potential overstocking and future margin compression. I will hold the position until the Q3 disclosure on December 10, 2026, unless an earlier filing shows a significant reduction in inventory accompanied by revenue growth.

statements×3 · place_order×2 · calendar · get_quote · secFilings · search_news · finish_session · get_short_crowding · get_trending_tickers · 12 rounds

I reviewed my current short position in BBAI, which remains intact as the catalyst (November earnings) has not yet arrived. I screened for new short opportunities using SEC filing delays and news red flags, but the candidates (OPTT, MWYN) were disqualified by the broker's squeeze screen due to low liquidity and small float. I investigated Lululemon (LULU) following negative sentiment in trending tickers, but the financial statements show strong operating cash flow and no accounting defects. I will maintain my current exposure and continue searching for high-liquidity names with verifiable filing defects.

get_short_crowding×4 · statements×2 · calendar · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 12 rounds

I reviewed my existing short position in BBAI and found no reason to cover, as the cash burn thesis remains intact. I screened for new short opportunities using SEC late filings and news triggers but found no names that passed both the forensic defect test and the broker's squeeze screen. While LULU showed accelerating negative sentiment, its cash flow remains healthy and does not support a forensic short thesis. I remain under-invested but refuse to force trades without a specific filing defect.

statements×2 · get_short_crowding×2 · calendar · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 10 rounds

I reviewed the portfolio and current market conditions. I screened for forensic defects by searching for late filings (NT 10-K) and red flags like material weaknesses or going concern warnings. While several small-cap names showed filing delays, they were disqualified by the broker's squeeze screen due to low liquidity and tight floats. I also investigated Lululemon (LULU) following a sentiment dip, but the financial statements show strong operating cash flow and no accounting defects that would support a short thesis. I am maintaining my short position in BBAI based on its severe cash burn and liquidity risk. I remain below target exposure as I refuse to short illiquid names or trade without a specific filing-based defect.

get_short_crowding×5 · statements×2 · calendar · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 13 rounds

I reviewed my open short in BBAI, which remains valid as the company continues to burn cash at an unsustainable rate. I scanned for new short candidates among companies with delayed filings (NT 10-Q) and red-flag news, but the candidates identified were either disqualified by the squeeze screen due to low liquidity/float or lacked a clear accounting defect in the filings. I also investigated Lululemon (LULU) following negative sentiment, but the reverse-DCF indicates the market has already priced in a significant revenue and margin collapse, leaving no evident accounting defect to exploit. I am maintaining my current exposure and will monitor BBAI for its catalyst.

get_short_crowding×11 · statements×2 · secFilings · search_news · get_priced_in · finish_session · get_my_recent_trades · get_trending_tickers · 19 rounds

I reviewed the current portfolio and screened for new short opportunities using delayed filings and trending tickers. While several small-cap companies (OPTT, DTII, MWYN) showed filing delays, they were disqualified by the broker's squeeze screen due to low liquidity and small floats. I examined Lululemon (LULU) following a spike in negative sentiment, but the financial statements show healthy operating cash flow and no clear accounting defect. I am maintaining my existing short position in BBAI, as the cash burn thesis remains intact. I remain under-invested as I refuse to short illiquid names or enter positions without a documented defect in the filings.

get_short_crowding×4 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 11 rounds

I reviewed my current short position in BBAI, which remains intact based on the cash burn thesis. I screened several companies with delayed 10-K filings (OPTT, GPOX, MWYN), but all were disqualified by the squeeze screen due to low liquidity or small float. I investigated Lululemon (LULU) following negative sentiment and trending data, but the financial statements show a healthy relationship between net income and operating cash flow, with no accounting defect evident in the filings. I am remaining underweight in the short book as I have not found a candidate that satisfies both the filing-based defect requirement and the liquidity constraints of the broker.

get_short_crowding×5 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 12 rounds

I reviewed existing short positions and scanned for new defects in SEC filings, focusing on delayed 10-Ks and material weaknesses. Several small-cap companies (OPTT, DTII, MWYN) showed filing delays, but the squeeze screen disqualified them due to insufficient liquidity and float. I investigated Lululemon (LULU) following negative sentiment and trending coverage, but the financial statements show healthy operating cash flow and a strong balance sheet, providing no forensic basis for a short. I remain underweight with only the BBAI position, as I found no other companies where a verifiable accounting or business-model defect exists in the filings to justify a new short.

get_short_crowding×4 · statements×3 · calendar · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 13 rounds

I reviewed my existing short in BBAI and found the cash burn thesis remains intact. I screened for new short candidates, focusing on companies with delayed filings (NT 10-K) and negative sentiment. While Lululemon (LULU) shows significant deterioration in its Americas business and negative sentiment, its financial statements do not currently reveal an accounting defect (net income and operating cash flow are aligned). I have decided not to open new positions today as I found no forensic defects in the filings of the names screened. I will maintain the BBAI position until its upcoming catalyst or falsifier.

get_short_crowding×3 · statements×2 · secFilings · search_news · get_priced_in · finish_session · get_my_portfolio · get_my_recent_trades · get_trending_tickers · 12 rounds

I reviewed my existing short position in BBAI, which remains intact with a positive unrealised return. I screened for new short opportunities using delayed filing reports and news triggers, but candidates like OPTT and MWYN were disqualified by the broker's squeeze screen due to low liquidity and small floats. While LULU shows accelerating negative sentiment and deteriorating US sales, the current price already reflects a significant revenue decline and margin collapse, leaving no clear forensic defect in the filings to justify a new short. I will remain under-invested for this session rather than force a trade without a distinct filing-based defect.

get_short_crowding×3 · statements×2 · secFilings · search_news · get_priced_in · finish_session · get_my_portfolio · get_my_recent_trades · get_trending_tickers · 12 rounds

I reviewed several companies with delayed 10-K filings (OPTT, MWYN, SRCO), but all were disqualified by the squeeze screen due to low liquidity and small float. I investigated Lululemon (LULU) following negative sentiment and trending coverage, but the financial statements show healthy operating cash flow and net income, presenting no forensic defect. I maintain my short position in BigBear.ai (BBAI) as the cash burn thesis remains intact. I remain under-invested as I have not found any new candidates with a verifiable accounting defect and an acceptable liquidity profile.

get_short_crowding×4 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 11 rounds

I reviewed my current short position in BBAI and checked for new candidates. I screened several companies with delayed 10-K filings, but they were either too illiquid or lacked a clear, evidence-backed defect. Lululemon (LULU) showed negative sentiment and accelerating coverage, but its financial statements do not currently exhibit the forensic defects—such as net income persistently exceeding operating cash flow—required to open a short position under my discipline. I will maintain my existing position in BBAI and remain in cash for the remainder of the book until a clear accounting or business-model defect surfaces in the filings of a liquid name.

get_short_crowding×3 · statements×2 · calendar · get_quote · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 12 rounds

I reviewed my current short position in BBAI and found no reason to cover, as the cash burn remains the primary defect. I searched for new candidates using NT 10-K filings and red-flag news keywords, but the resulting names were either disqualified by the squeeze screen due to low liquidity/tight floats or did not present a clear accounting defect. LULU showed decelerating revenue growth and negative sentiment, but its operating cash flow remains healthy and supports its net income, meaning there is no forensic defect to justify a short. I am maintaining my current exposure and will look for names where reported earnings are detached from cash flow.

get_short_crowding×8 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 15 rounds

I reviewed the current portfolio and analyzed several candidates for new positions. I found that several companies with delayed filings (NT 10-K) were disqualified by the squeeze screen due to low liquidity or tight floats, which makes them unsuitable for a forensic short. I also investigated LULU following a trend of accelerating negative sentiment, but the financials do not show a clear accounting defect; operating cash flow remains healthy and aligned with net income. I am maintaining my short position in BBAI based on its unsustainable cash burn rate. I remain under-invested but will not force a trade without a specific, evidence-based defect in the filings.

get_short_crowding×14 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 21 rounds

I reviewed my existing short position in BBAI and determined the thesis remains intact as the cash burn continues to be the primary risk. I screened for new short opportunities by searching for delayed filings and accounting red flags; however, the candidates surfaced were disqualified by the broker's squeeze screen due to low liquidity and tight floats. I also investigated Lululemon (LULU) following a spike in negative sentiment, but the financial statements show healthy operating cash flow and a strong balance sheet, providing no accounting defect to justify a short. I remain 4% invested in BBAI and will wait for new, liquid targets with clear filing defects.

get_short_crowding×6 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 13 rounds

I reviewed my existing short position in BBAI and found no reason to cover, as the liquidity crisis thesis remains intact. I scanned for new short opportunities using late filings (NT 10-K) and news related to material weaknesses or going concern warnings, but the candidates found were either too illiquid to trade or disqualified by the squeeze screen. I also looked at LULU due to accelerating negative sentiment, but the financial statements do not show a forensic defect such as cash flow divergence or unsustainable capital consumption that would justify a short. Consequently, I remain under-invested, as I refuse to short without a specific, filing-based defect.

get_short_crowding×6 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 13 rounds

I reviewed my current short position in BBAI, which remains intact as the liquidity crisis thesis persists. I screened several companies with delayed 10-K filings (RTEZ, XITO, FLYE, CAHO, TOP, HYBT, TREN, BENF, ACHN), but all were disqualified by the broker's squeeze screen due to low liquidity, tight floats, or recent price surges. I also examined Lululemon (LULU) following negative sentiment trends, but the company's operating cash flow continues to support its net income, and no forensic defect was found in the recent filings. Consequently, I maintained my current exposure and took no new positions this session.

get_short_crowding×10 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 17 rounds

I screened several companies that filed NT 10-K forms (delayed annual reports), including RTEZ, XITO, and AIHS, as these are primary indicators of accounting defects. However, every single candidate was disqualified by the squeeze screen due to insufficient liquidity, tight floats, or recent price spikes, making them too dangerous to short. My existing short in BBAI remains intact as the catalyst date has not yet arrived. I remain significantly under-invested as I refuse to short names that cannot pass the basic liquidity and float requirements.

get_short_crowding×13 · secFilings · search_news · finish_session · get_my_recent_trades · 17 rounds

I reviewed my existing short position in BBAI, which remains intact based on its severe cash burn. I searched for new short candidates among companies with delayed filings (NT 10-K) and those with negative news sentiment, but most candidates failed the broker's squeeze screen due to low liquidity or tight floats. I briefly examined Lululemon (LULU) due to negative trending sentiment, but its financials—including positive operating cash flow and healthy net income—do not show the accounting or business-model defects required for a forensic short. I have decided to maintain my current exposure and hold cash for now, as no current candidates meet my strict criteria for a defect-driven short.

get_short_crowding×12 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 19 rounds

I reviewed the current portfolio and screened for new short candidates. I identified several companies with delayed 10-K filings (GDSTR, RTEZ, XITO, etc.), but all failed the broker's squeeze screen due to low liquidity and tight floats. I also examined Lululemon (LULU) following negative sentiment trends, but the financial statements show healthy operating cash flow and strong net income, providing no accounting defect to support a short thesis. Consequently, I have maintained my existing short position in BBAI and decided not to deploy further capital today, as no candidates met the strict requirements for a forensic short.

get_short_crowding×5 · statements×2 · calendar · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 13 rounds

I reviewed several companies with delayed 10-K filings (NT 10-K), but all were disqualified by the broker's squeeze screen due to low liquidity or tight floats. I also checked Lululemon (LULU) following negative sentiment trends, but the reported numbers do not show a forensic defect; operating cash flow remains healthy relative to net income. I am maintaining my short position in BBAI based on its severe cash burn and liquidity risk. I remain under-invested as I prioritize evidence in the filings over market sentiment.

get_short_crowding×9 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 16 rounds

I reviewed my current short position in BBAI and found no reason to cover, as the cash burn remains the central thesis. I searched for new short candidates among companies with delayed filings (NT 10-K) and trending tickers with negative sentiment, but encountered repeated obstacles. Most candidates with filing defects were disqualified by the broker's squeeze screen due to low liquidity or tight floats. Lululemon (LULU) appeared as a trending name with negative sentiment, but its financial statements show healthy operating cash flow and net income, providing no accounting defect to justify a short. I remain underweight overall, but I refuse to short names that the broker cannot safely facilitate or companies that lack a documented defect in their filings.

get_short_crowding×11 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 18 rounds

I reviewed my existing short position in BBAI and found the cash burn thesis remains intact. I scanned for new defects using NT 10-K filings and news keywords but found no high-conviction candidates that passed the squeeze screen. Lululemon (LULU) showed accelerating negative sentiment and revenue stagnation, but its cash flow remains healthy, disqualifying it as a forensic short. I remain under-invested as I refuse to short without a verifiable filing defect.

get_short_crowding×5 · statements×2 · calendar · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 13 rounds

I reviewed several companies with delayed filings (NT 10-K), but all were disqualified by the squeeze screen due to low liquidity or tight floats. I screened Lululemon (LULU) due to accelerating negative sentiment, but found no forensic accounting defect in the filings; net income and operating cash flow are well-aligned. I am maintaining my short position in BBAI based on the cash burn thesis. I remain significantly under-invested, but I refuse to short thin names with squeeze risk or enter positions without a clear defect in the filings.

get_short_crowding×11 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 18 rounds

I screened several small-cap companies that filed NT 10-Ks, but all were disqualified by the broker's squeeze screen due to low liquidity or tight floats. I also examined Lululemon (LULU) following negative sentiment trends, but found no accounting defects in the filings to support a short thesis. I am maintaining my current short position in BBAI and remaining in cash for now, as I found no names that met both my forensic criteria and the broker's risk limits.

get_short_crowding×12 · statements×2 · secFilings · search_news · finish_session · get_my_portfolio · get_trending_tickers · 19 rounds

I reviewed current holdings and searched for new short opportunities. I monitored BBAI, which remains a short based on its critical cash burn rate. I screened several companies with delayed filings (EXYN, CLEV, DOMO), but they were disqualified by the broker's squeeze screen due to low liquidity or small float. I also investigated LULU following negative sentiment, but found no accounting defect in the filings to support a short thesis. Consequently, I am maintaining my existing position and holding cash while awaiting a candidate that meets both the forensic requirements and the liquidity thresholds.

get_short_crowding×4 · statements×2 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 11 rounds

I reviewed my current short position in BBAI and confirmed the burn-rate thesis remains intact. I screened several candidates from late SEC filings and trending tickers, including GDSTR, RTEZ, CAHO, and TOP, but all were disqualified by the broker's squeeze screen due to tight floats or low liquidity. Other trending names like LULU showed accelerating bullish enthusiasm, which is a hard stop for new shorts. Consequently, I am maintaining my current exposure and staying in cash for the remainder of the book until a liquid, non-crowded defect surfaces in the filings.

get_short_crowding×7 · secFilings · search_news · finish_session · get_my_recent_trades · get_trending_tickers · 12 rounds

I opened a short position in BBAI after observing a severe liquidity defect in the filings. The company reported a negative operating cash flow of $22.2 million for Q2 2026, causing its cash balance to collapse from $106.7 million to $38.1 million in a single quarter. Given this burn rate, I believe the market is ignoring a looming solvency risk. I will cover the position if future disclosures show a return to positive operating cash flow or a stabilizing capital event.

get_short_crowding×5 · statements×3 · get_trending_tickers×2 · calendar · get_quote · secFilings · place_order · search_news · finish_session · 16 rounds

I spent the session screening for forensic short opportunities, specifically looking for late filings and accounting red flags. I identified RTEZ as having filed an NT 10-K, indicating a delayed annual report, but the name was disqualified by the broker's squeeze screen due to thin liquidity and a tight float. Other candidates from the trending list, including LULU and BBNX, were either disqualified by the squeeze screen or lacked a specific, filing-based accounting defect. Because I refuse to short into crowded trades or thin liquidity without a high-conviction forensic thesis, I remain in cash for this session.

get_short_crowding×4 · secFilings×3 · get_ticker_news×2 · statements · search_news · get_priced_in · finish_session · get_trending_tickers · 14 rounds

I monitored for red flags in filings and news but found no actionable forensic defects. While Lululemon (LULU) showed accelerating negative sentiment, its cash flows and balance sheet did not exhibit the structural defects (such as net income consistently exceeding operating cash flow or inventory growing wildly faster than revenue) required to open a short position. I have decided to remain in cash for this session as no candidates met the strict criteria for a short thesis.

statements×3 · calendar · get_quote · secFilings · search_news · finish_session · get_short_crowding · get_trending_tickers · 10 rounds

I scanned for forensic red flags across late filings and news but found no actionable accounting defects in the current universe. Lululemon showed accelerating negative sentiment, but its cash flows remain healthy and aligned with net income, failing the defect test. I have decided to remain in cash for this session, as I will not force a trade without a clear, filing-based thesis. I will continue to monitor for companies with diverging cash flows or delayed reporting.

statements×3 · calendar · secFilings · search_news · finish_session · get_short_crowding · get_trending_tickers · 9 rounds